ETN
78
-2
CMCSA
59
2
MAR
65
2
VRSK
54
16
AIV
68
-2
HAL
50
4
ADT
43
-3
VRSN
60
3
ROST
51
-3
AES
58
3
STX
64
-2
AMAT
59
-5
CL
62
3
WDC
59
-2
LRCX
53
-3
EIX
74
2
EQT
54
3
DVA
75
2
NFLX
55
-2
EXPD
61
2
ETN
78
-2
CMCSA
59
2
MAR
65
2
VRSK
54
16
AIV
68
-2
HAL
50
4
ADT
43
-3
VRSN
60
3
ROST
51
-3
AES
58
3
STX
64
-2
AMAT
59
-5
CL
62
3
WDC
59
-2
LRCX
53
-3
EIX
74
2
EQT
54
3
DVA
75
2
NFLX
55
-2
EXPD
61
2
Financhill
Back

PIMCO Global Stocksplus & Income Fund Vs. Sarepta Therapeutics Industry Stock Comparison

Buy
69

PGP
PIMCO Global Stocksplus & Income Fund

Last Price:
8.26
Seasonality Move:
-3.28%
Sell
36

SRPT
Sarepta Therapeutics

Last Price:
124.65
Seasonality Move:
-1.39%
Buy
69
PIMCO Global Stocksplus & Income Fund (PGP) is a Buy

Is PIMCO Global Stocksplus & Income Fund a Buy, Sell or Hold?

  • The current PIMCO Global Stocksplus & Income Fund [PGP] share price is $8.27. The Score for PGP is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
  • PGP is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
36
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $124.53. The Score for SRPT is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PGP Stock Price Chart

What is PIMCO Global Stocksplus & Income Fund's stock price today?

  • The PIMCO Global Stocksplus & Income Fund share price today is $8.27
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PGP is experiencing slight selling pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $124.53
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight selling pressure.

PGP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.11 Buy
Relative Strength Index (14 RSI): 76.34 Buy
Chaikin Money Flow: -5805 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.94 - 8.16) Buy
Bollinger Bands (100): (7.5 - 7.94) Buy

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.18 Sell
Relative Strength Index (14 RSI): 35.54 Sell
Chaikin Money Flow: -49995 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (124.27 - 135.95) Sell
Bollinger Bands (100): (123.89 - 147.49) Sell

PGP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 8.18 Buy
20-day SMA: 8.07 Buy
50-day SMA: 7.85 Buy
200-day SMA: 7.59 Buy
8-day EMA: 8.19 Buy
20-day EMA: 8.08 Buy
50-day EMA: 7.91 Buy
200-day EMA: 7.6 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 125.45 Sell
20-day SMA: 127.75 Sell
50-day SMA: 135.2 Sell
200-day SMA: 127.53 Sell
8-day EMA: 125.39 Sell
20-day EMA: 128.04 Sell
50-day EMA: 132.59 Sell
200-day EMA: 128.64 Sell

PIMCO Global Stocksplus & Income Fund Earnings Growth & PGP Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.96 per share, an increase next quarter of $2.81 per share, an increase this year of $4.41 per share, and an increase next year of $9.14 per share.

PIMCO Global Stocksplus & Income Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):